Immunogen, inc. (IMGN)
CashFlow / Yearly
Dec'19Dec'18Dec'17Jun'16Jun'15Jun'14Jun'13Jun'12Jun'11Jun'10
Cash flows from operating activities:
Net loss

-104,100

-168,843

-96,012

-144,817

-60,739

-71,364

-72,811

-73,319

-58,274

-50,912

Adjustments to reconcile net loss to net cash (used for) provided by operating activities:
Non-cash royalty revenue related to sale of future royalties

47,415

32,154

28,142

25,299

5,484

-

-

-

-

-

Non-cash interest expense on liability related to sale of future royalties and convertible senior notes

16,879

10,631

13,682

20,130

5,437

-

-

-

-

-

Non-cash debt conversion expense

-

-

22,915

-

-

-

-

-

-

-

Depreciation and amortization

4,000

7,400

6,000

5,327

5,513

4,598

4,641

4,633

4,937

4,838

(Gain) loss on sale/disposal of fixed assets and impairment charges

-1,689

-115

-239

21

-7

-20

21

-51

-9

-41

Operating lease right-of-use asset impairment

694

-

-

-

-

-

-

-

-

-

Gain on sale of marketable securities

-

-

-

-

-

-

-

-

341

-

Amortization of deferred lease incentive obligation

-

-

-

-

-

-

-

-

-

-979

Gain on forward contracts

-

-

-

-

-

2

197

-173

189

-219

Non-cash licensing fee

-

-

-

-

-

12,830

-

-

-

-

Stock and deferred share unit compensation

14,167

16,807

11,325

22,248

15,715

16,080

12,751

10,252

5,778

4,640

Deferred rent

-

95

-91

-161

-195

-297

109

109

4

-55

Change in operating assets and liabilities:
Accounts receivable

5,799

-948

623

-4,205

3,192

1,896

-129

-4,539

2,873

49

Unbilled revenue/reimbursement

384

-1,963

-4,198

695

-615

-792

925

-292

-107

1,034

Inventory

-

-1,038

-1,154

-2,028

-15

2,247

-585

808

-762

-594

Contract asset

3,131

500

-

-

-

-

-

-

-

-

Prepaid and other current assets

963

1,495

-2,419

706

1,855

-571

181

-253

1,038

386

Operating lease right-of-use assets

1,331

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-2,231

-319

-1,018

-574

-366

Other assets

75

-88

777

2,456

761

-4

43

16

-38

171

Accounts payable

-1,045

2,667

771

2,649

3,319

321

1,103

182

149

1,820

Accrued compensation

-2,189

323

4,527

2,378

1,481

712

1,211

219

522

61

Other accrued liabilities

-6,146

3,839

4,375

-1,434

3,248

-394

481

133

-375

1,393

Deferred revenue

46,630

-9,165

61,540

-8,318

-20,155

-16,675

-7,232

18,219

42,229

-1,080

Operating lease liability

-2,505

-

-

-

-

-

-

-

-

-

Proceeds from landlord for tenant improvements

-

-

-

-144

-1,350

-472

-

-

-

-

Net cash (used for) provided by operating activities

-88,367

-166,422

7,645

-124,476

-55,291

-53,650

-60,299

-34,288

-7,989

-40,584

Proceeds from maturities or sales of marketable securities

-

-

-

-

-

-

-

-

1,201

834

Purchases of property and equipment

2,845

5,246

1,116

10,376

7,425

8,184

3,770

2,908

2,029

1,534

Proceeds from sale of equipment

2,312

-

-

-

-

-

-

-

-

-

Net cash provided by (used for) investing activities

-533

-5,246

-1,116

-10,376

-7,425

-8,185

-3,696

-2,968

-660

-882

Cash flows from financing activities:
Payments from settlement of forward contracts

-

-

-

-

-

1

-74

60

-168

182

Proceeds from issuance of common stock under stock plans

2,873

4,301

650

5,161

4,429

9,136

4,026

6,988

2,719

3,462

Proceeds from common stock issuance, net of $229 of transaction costs

-

162,512

101,663

-

-

-

93,991

-

87,980

77,521

Proceeds from Royalties Received

-

-

-

-

194,135

-

-

-

-

-

Fees for debt conversion

-

-

1,699

-

-

-

-

-

-

-

Proceeds from issuance of convertible 4.5% notes, net of $3,392 of transaction costs

-

-

-

96,608

-

-

-

-

-

-

Net cash provided by financing activities

2,873

166,813

100,614

101,769

198,564

9,136

98,017

6,988

90,699

80,983

Net change in cash and cash equivalents

-86,027

-4,855

107,143

-

-

-

-

-

-

-

Net change in cash and cash equivalents

-

-

-

-33,083

135,848

-52,699

34,022

-30,268

82,050

39,517

Supplemental cash flow information:
Cash paid during the year for interest

95

95

4,685

-

-

-

-

-

-

-